Covid19: Clinical Trials

11 trials for Covid19, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 withdrawn, 2 terminated, 1 active not recruiting. 11 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 111Completed 4, Withdrawn 3, Terminated 2, Active not recruiting 1, Unknown 1

Follow Covid19: new trials by email Literature Review of Covid19 trials Research Report on Covid19

Trials (filtered) newest first · largest first

All 11 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proof-of-Concept Clinical Pharmacology Trial for COVID-19 Antigen Presentation Therapeutic Biologic Mix
COVID-19 Therapeutic Biologic Mix - NOVAVAX COVID-19 VACCINE plus BCG Vaccine Mix for percutaneous use - Covid19
Early Phase 1Active not recruitingHan Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair202025-05-182026-06-10
S-Nitrosylation Therapy of COVID-19
SNO, Nitrogen gas - SARS-CoV2 Infection, Covid19
Early Phase 1WithdrawnJames Reynolds2021-08-052025-05-07
Oral Rinse to Reduced Expelled Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) During COVID-19 Infection
Mouthwash Product - Covid19
Early Phase 1CompletedRutgers, The State University of New Jersey342021-07-212026-01-30
Safety, Reactogenicity and Immunogenicity Study of ReCOV
Recombinant two-component COVID-19 vaccine (CHO cell), Placebo - Covid19
Early Phase 1CompletedJiangsu Rec-Biotechnology Co., Ltd.1002021-06-182022-09-27
Immune Response to the COVID-19 Vaccine
SARS-COV2 Pfizer Vaccine - Covid19, Cancer
Early Phase 1CompletedUniversity of Arizona202021-06-072022-05-20
Povidone-Iodine Rinses in the Management of COVID-19
Povidone-iodine, Placebo - Covid19
Early Phase 1TerminatedSt. Paul's Hospital, Canada52021-01-192022-07-11
Glutathione, Oxidative Stress and Mitochondrial Function in COVID-19
Glycine, N-acetylcysteine, Alanine - Covid19
Early Phase 1TerminatedBaylor College of Medicine42021-01-112024-06-26
Study on the Use of Sarilumab in Patients With COVID-19 Infection
Sarilumab Prefilled Syringe - COVID19
Early Phase 1WithdrawnASST Fatebenefratelli Sacco2021-01-012023-02-03
Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)
Fluoxetine, Placebo - Covid19
Early Phase 1WithdrawnMilton S. Hershey Medical Center2020-11-012020-12-24
Intranasal Heparin Tolerability Study
Intranasal heparin sodium (porcine) - Covid19
Early Phase 1CompletedJoshua Sharp62020-10-092021-04-30
Efficacy and Safety of Recovered Covid 19 Plasma Transfusion to Covid 19 Severly Ill Patients
recovered covid 19 patients plasma - Covid19
Early Phase 1UnknownSouth Valley University302020-05-292020-08-28

Narrower conditions

COVID-19 (11)  ·  Coronavirus Infections (1)  ·  Dyspnea (1)  ·  Neoplasms (1)  ·  Respiratory Insufficiency (1)

Broader conditions

Coronaviridae Infections (11)  ·  Infections (11)  ·  Lung Diseases (11)  ·  Nidovirales Infections (11)  ·  Pneumonia (11)  ·  Pneumonia, Viral (11)  ·  RNA Virus Infections (11)  ·  Respiratory Tract Diseases (11)  ·  Respiratory Tract Infections (11)  ·  Virus Diseases (11)  ·  Coronavirus Infections (10)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

Acetylcysteine (1)  ·  Alanine (1)  ·  Fluoxetine (1)  ·  Glycine (1)  ·  NVX-CoV2373 adjuvated lipid nanoparticle (1)  ·  Nitrogen (1)  ·  Povidone-Iodine (1)  ·  Saline Solution (1)  ·  sarilumab (1)

Sponsors

ASST Fatebenefratelli Sacco (1)  ·  Baylor College of Medicine (1)  ·  Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair (1)  ·  James Reynolds (1)  ·  Jiangsu Rec-Biotechnology Co., Ltd. (1)  ·  Joshua Sharp (1)  ·  Milton S. Hershey Medical Center (1)  ·  Rutgers, The State University of New Jersey (1)  ·  South Valley University (1)  ·  St. Paul's Hospital, Canada (1)  ·  University of Arizona (1)

Countries

United States (7)  ·  Canada (1)  ·  Egypt (1)  ·  Italy (1)  ·  New Zealand (1)

Top investigators

Bill Gurley, PhD (1)  ·  David Alland, MD (1)  ·  Erika Saunders, MD (1)  ·  Massimo Galli, Professor (1)  ·  Padmapriya Banada, PhD (1)  ·  Rachna Shroff, MD (1)  ·  Robert Schilz, DO, PhD (1)  ·  Yingda L Xie, MD (1)

Results publications

PMID 34013969, PMID 34594036, PMID 36734509, PMID 37162745, PMID 38103161